Aurobindo Pharma Ltd. (AUROPHARMA) Share Price Hits Fresh 52-Week High

Aurobindo Pharma Ltd. at Rs 1,671, up 0.36% today, touched a fresh 52-week high of Rs 1,677.10. The company’s market capitalisation stands at Rs 94,477.05 crore.

Aurobindo Pharma Ltd. Share Price was at Rs 1,671 on 13 August 2026, up 0.36% from the previous close of Rs 1,664.95, after the stock touched a fresh 52-week high of Rs 1,677.10. With a market capitalisation of Rs 94,477.05 crore, the move places the company among notable market movers being tracked in Stock Market Today and Share Market Today screens.

The verified data confirms the price event clearly: Aurobindo Pharma Ltd. (AUROPHARMA) opened at Rs 1,674.60, traded between Rs 1,661 and Rs 1,677.10, and recorded turnover of Rs 0.44 crore on volume of 2,626 shares. The supplied data establishes the new one-year high, but it does not establish a company-specific catalyst for why the stock is rising today. Even so, Aurobindo Pharma Ltd. Stock News is attracting attention because fresh yearly highs often bring the stock into momentum and 52 Week High Stocks discussions.

For investors following Aurobindo Pharma Ltd. Share Price Today, the important context is not just the intraday high. The stock is now being watched alongside its valuation profile, profitability ratios and healthcare sector positioning. Univest notes that the company’s P/E of 68.39 and P/B of 10.82 sit against sector-wide benchmarks, while ROE of 18.65 and ROCE of 22.17 add important fundamental context. The next step is to examine what today’s price action and supplied financial metrics actually show.

Aurobindo Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,671
Previous Close	Rs 1,664.95
Today's Change	+Rs 6.05 (+0.36%)
Day Open	Rs 1,674.6
Fresh 52-Week High	Rs 1,677.1
Day Low	Rs 1,661
Current Volume	2,626
Turnover	Rs 0.44 crore
Market Capitalisation	Rs 94,477.05 crore

Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,671. versus the previous close of Rs 1,664.95, a rise of 0.36%. The stock opened at Rs 1,674.6, reached Rs 1,677.1, touched Rs 1,661. Reported volume was 2,626.

Aurobindo Pharma Ltd. Share Price Today reflects a confirmed fresh 52-week high, with the stock trading above its previous close and near its intraday peak. The day’s range, opening level, turnover and volume together show that the stock has entered the market’s one-year high list, even though the supplied data does not identify a company-specific trigger.

Aurobindo Pharma Ltd. Share Price moved up by Rs 6.05 to Rs 1,671 from the previous close of Rs 1,664.95. The stock opened at Rs 1,674.60, which meant the session began above the previous close, and it later climbed to Rs 1,677.10, marking the fresh 52-week peak. The day low stood at Rs 1,661, showing that intraday swings remained relatively contained around the prevailing trading zone.

From a price action perspective, the move is notable because the stock not only printed a new one-year high but also stayed close to that level during the observed update. That tends to keep Aurobindo Pharma Ltd. Share News relevant in intraday market updates, especially when traders scan for breakout stocks and momentum stocks. At the same time, turnover of Rs 0.44 crore and current volume of 2,626 shares indicate that today’s move should be read alongside the company’s broader valuation and sector standing, rather than as a standalone signal.

For readers searching Aurobindo Pharma Ltd. Share Price Live or Aurobindo Pharma Ltd. News Today, the factual takeaway is simple: the stock has registered a fresh yearly high, is trading modestly above the prior close, and remains a name to watch in ongoing market news coverage. That naturally leads to a deeper look at the company’s fundamental analysis.

Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 94,477.05 crore
P/E Ratio	68.39x
P/B Ratio	10.82x
ROE	18.65%
ROCE	22.17%

Aurobindo Pharma Ltd. was valued at a P/E ratio of 68.39x, a P/B ratio of 10.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 18.65% and ROCE of 22.17%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	68.39x
Benchmark Median P/E	21.07x
Benchmark Average P/E	58.79x
Benchmark P/E Range	0x to 3,374.81x
Company P/B Ratio	10.82x
Benchmark Median P/B	1.92x
Company ROE	18.65%
Benchmark Median ROE	10.92%
Company ROCE	22.17%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 94,477.05 crore
Benchmark Median Market Cap	Rs 140.78 crore

Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare.

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 68.39x, which is above the benchmark median of 21.07x, a difference of +224.58%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 18.65%, which is above the benchmark median of 10.92%, a difference of +70.79%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 22.17%, which is above the benchmark median of 13.29%, a difference of +66.82%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Beta Drugs Ltd.	BETA	2,958.04	68.39	10.82	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,596.51	34.07	7.02	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,559.74	171.25	3.13	13.9	12.97
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,474.06	44.25	1.76	-0.78	8.31
NGL Fine-Chem Ltd.	NGLFINE	2,137.26	43.8	6.4	27.9	33.91

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 68.39x compared with the displayed peer median of 44.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.65% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 22.17% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 94,477.05 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Aurobindo Pharma Ltd.

The stock is attracting attention because verified data shows a fresh one-year high, premium valuation multiples, above-benchmark profitability and a market capitalisation that is dramatically larger than the supplied sector and peer sets. That combination keeps the name relevant in Aurobindo Pharma Ltd. Stock News and broader market mover screens.

• Fresh price event: Aurobindo Pharma Ltd. Share Price touched Rs 1,677.10, its new 52-week high, and was trading at Rs 1,671, up 0.36% on the day.
• Intraday positioning: The stock opened at Rs 1,674.60, traded between Rs 1,661 and Rs 1,677.10, and stayed close to the session high during the observed update.
• Large market value: Market capitalisation stands at Rs 94,477.05 crore, making it far larger than the peer and sector benchmark figures supplied in this dataset.
• Valuation profile: P/E of 68.39 and P/B of 10.82 are above the sector median and average, indicating a premium market valuation.
• Profitability context: ROE of 18.65 and ROCE of 22.17 are above sector averages of 15.37 and 17.70, respectively.
• Sector relevance: The company sits within Healthcare, where the benchmark comparison covers 196 companies in the same sector.

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. is presented in the supplied data as a Healthcare sector company trading under the symbol AUROPHARMA. The available verified dataset for this article does not provide business segments, product lines, revenue mix or a longer company profile, so the factual company context here remains centred on its market presence, sector classification and valuation profile within healthcare.

Based on the supplied figures, Aurobindo Pharma Ltd. is one of the larger companies represented in this dataset, with a market capitalisation of Rs 94,477.05 crore. That scale alone makes the stock relevant in market updates when it reaches a fresh 52-week high. Its current valuation metrics, including a P/E of 68.39 and a P/B of 10.82, place it at a premium relative to broad healthcare sector medians, while profitability metrics of 18.65% ROE and 22.17% ROCE indicate strong returns compared with the benchmark averages supplied.

For readers following Aurobindo Pharma Ltd. Share Price, the key point is that the company is being tracked not just as a price breakout candidate but also as a large healthcare stock with notable profitability and premium market positioning. Univest will continue to monitor how the stock features in future market updates.

Track Aurobindo Pharma Ltd. Share Price on Univest

Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Aurobindo Pharma Ltd. Share Price through live price updates, 52-week levels, market capitalisation data, valuation ratios and broader stock analysis tools. For a stock that has just touched a fresh one-year high, keeping an eye on ongoing price action and updated market metrics can help frame the next set of factual observations.

Univest also helps users follow Aurobindo Pharma Ltd. Share Price Today alongside key ratios such as P/E, P/B, ROE and ROCE, as well as sector positioning and peer comparison. For readers scanning Aurobindo Pharma Ltd. Share Price Update or Aurobindo Pharma Ltd. Latest News, that provides a structured way to monitor verified data without turning the analysis into a recommendation.

Frequently Asked Questions

What is the latest Aurobindo Pharma Ltd. Share Price Today?

Ans. Aurobindo Pharma Ltd. Share Price Today was Rs 1,671 at the time of the update. The stock was up 0.36% or Rs 6.05 from the previous close of Rs 1,664.95 on 13 August 2026.

Did Aurobindo Pharma Ltd. hit a fresh 52-week high today?

Ans. Yes, Aurobindo Pharma Ltd. touched a fresh 52-week high of Rs 1,677.10 during the session. It opened at Rs 1,674.60 and traded within a day range of Rs 1,661 to Rs 1,677.10.

Why is Aurobindo Pharma Ltd. Share Price rising today?

Ans. The supplied data confirms that Aurobindo Pharma Ltd. Share Price is higher by 0.36% and has reached a fresh one-year high. However, the verified dataset for this article does not establish a company-specific catalyst behind the move.

What does today’s price action show for Aurobindo Pharma Ltd.?

Ans. Today’s price action shows the stock trading above its previous close and close to its intraday high. Aurobindo Pharma Ltd. opened at Rs 1,674.60, hit Rs 1,677.10, and turnover stood at Rs 0.44 crore.

What is the market capitalisation of Aurobindo Pharma Ltd.?

Ans. Aurobindo Pharma Ltd. has a market capitalisation of Rs 94,477.05 crore based on the supplied data. That is far above the healthcare sector benchmark median of Rs 140.78 crore and average of Rs 466.20 crore.

Is Aurobindo Pharma Ltd. expensive compared with the healthcare sector?

Ans. On the supplied numbers, Aurobindo Pharma Ltd. trades at a P/E of 68.39 and P/B of 10.82. Both are above the healthcare sector median of 21.07 and 1.92, and above the averages of 58.79 and 2.58.

How profitable is Aurobindo Pharma Ltd. based on current ratios?

Ans. The stock’s supplied profitability ratios are ROE of 18.65 and ROCE of 22.17. These are above the healthcare sector averages of 15.37 for ROE and 17.70 for ROCE, indicating stronger benchmark profitability.

How does Aurobindo Pharma Ltd. compare with selected peers?

Ans. Aurobindo Pharma Ltd. trades at higher valuation multiples than several supplied peers, while its profitability is stronger than many of them. Its market capitalisation of Rs 94,477.05 crore is also far above the peer range shown.

Which sector does Aurobindo Pharma Ltd. belong to?

Ans. Aurobindo Pharma Ltd. belongs to the Healthcare sector in the supplied dataset. The sector benchmark used in this article covers 196 same-sector companies, providing context for valuation, profitability and market capitalisation comparisons.

Where can investors track Aurobindo Pharma Ltd. Share Price updates?

Ans. Investors can track Aurobindo Pharma Ltd. Share Price updates on Univest for live price movement, 52-week levels, valuation ratios, peer comparison and broader market context. That helps monitor the stock after its fresh yearly high.